Besa Xhabija

Dr. Besa Xhabija

University of Michigan–Flint, Flint, Michigan, USA
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
BXBesa Xhabija
Besa Xhabija
BKBenjamin L. Kidder
Benjamin L. Kidder

3 June 2011 in Environmental Toxicology and Chemistry
Verified
Journal Article
Closed access
PDF file
KTKeith Tierney
Keith Tierney
MSMark A Sekela
Mark A Sekela
CCChristine E Cobbler
Christine E Cobbler
BXBesa Xhabija
Besa Xhabija
MGMelissa Gledhill
Melissa Gledhill
BZBarbara S. Zielinski
Barbara S. Zielinski

1 August 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
BXBesa Xhabija
Besa Xhabija
PVPanayiotis O. Vacratsis
Panayiotis O. Vacratsis
Receptor-mediated endocytosis 8 (RME-8) is a DnaJ domain containing protein implicated in translocation of Hsc70 to early endosomes for clathrin removal during retrograde transport. Previously, we have demonstrated that RME-8 associates with early endosomes in a phosphatidylinositol 3-phosphate (PI(3)P)-dependent fashion. In this study, we have now identified amino acid determinants required for PI(3)P binding within a region predicted to adopt a pleckstrin homology-like fold in the N terminus of RME-8. The ability of RME-8 to associate with PI(3)P and early endosomes is largely abolished when residues Lys17, Trp20, Tyr24, or Arg26 are mutated resulting in diffuse cytoplasmic localization of RME-8 while maintaining the ability to interact with Hsc70. We also provide evidence that RME-8 PI(3)P binding regulates early endosomal clathrin dynamics and alters the steady state localization of the cation-independent mannose 6-phosphate receptor. Interestingly, RME-8 endosomal association is also regulated by the PI(3)P-binding protein SNX1, a member of the retromer complex. Wild type SNX1 restores endosomal localization of RME-8 W20A, whereas a SNX1 variant deficient in PI(3)P binding disrupts endosomal localization of wild type RME-8. These results further highlight the critical role for PI(3)P in the RME-8-mediated organizational control of various endosomal activities, including retrograde transport.

15 April 2011 in FEBS Letters
Verified
Journal Article
Closed access
BXBesa Xhabija
Besa Xhabija
GTGregory S. Taylor
Gregory S. Taylor
AFAkemi Fujibayashi
Akemi Fujibayashi
KSKiyotoshi Sekiguchi
Kiyotoshi Sekiguchi
PVPanayiotis O. Vacratsis
Panayiotis O. Vacratsis

13 December 2018 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
RRRayna Rosati
Rayna Rosati
LPLisa Polin
Lisa Polin
CDCharles Ducker
Charles Ducker
JLJing Li
Jing Li
XBXun Bao
Xun Bao
MRManohar Ratnam
Manohar Ratnam
Purpose: Testosterone suppression in prostate cancer is limited by serious side effects and resistance via restoration of androgen receptor (AR) functionality. ELK1 is required for AR-dependent growth in various hormone-dependent and castration-resistant prostate cancer models. The amino-terminal domain of AR docks at two sites on ELK1 to coactivate essential growth genes. This study explores the ability of small molecules to disrupt the ELK1–AR interaction in the spectrum of prostate cancer, inhibiting AR activity in a manner that would predict functional tumor selectivity. Experimental Design: Small-molecule drug discovery and extensive biological characterization of a lead compound. Results: We have discovered a lead molecule (KCI807) that selectively disrupts ELK1-dependent promoter activation by wild-type and variant ARs without interfering with ELK1 activation by ERK. KCI807 has an obligatory flavone scaffold and functional hydroxyl groups on C5 and C3′. KCI807 binds to AR, blocking ELK1 binding, and selectively blocks recruitment of AR to chromatin by ELK1. KCI807 primarily affects a subset of AR target growth genes selectively suppressing AR-dependent growth of prostate cancer cell lines with a better inhibitory profile than enzalutamide. KCI807 also inhibits in vivo growth of castration/enzalutamide-resistant cell line–derived and patient-derived tumor xenografts. In the rodent model, KCI807 has a plasma half-life of 6 hours, and maintenance of its antitumor effect is limited by self-induced metabolism at its 3′-hydroxyl. Conclusions: The results offer a mechanism-based therapeutic paradigm for disrupting the AR growth-promoting axis in the spectrum of prostate tumors while reducing global suppression of testosterone actions. KCI807 offers a good lead molecule for drug development.

1 January 2017 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
QGQiudi Geng
Qiudi Geng
BXBesa Xhabija
Besa Xhabija
CKColleen Knuckle
Colleen Knuckle
CBChristopher A. Bonham
Christopher A. Bonham
PVPanayiotis O. Vacratsis
Panayiotis O. Vacratsis
Human YVH1 (hYVH1), also known as dual specificity phosphatase 12 (DUSP12), is a poorly characterized atypical dual specificity phosphatase widely conserved throughout evolution. Recent findings have demonstrated that hYVH1 expression affects cellular DNA content and is a novel cell survival phosphatase preventing both thermal and oxidative stress-induced cell death, whereas studies in yeast have established YVH1 as a novel 60S ribosome biogenesis factor. In this study, we have isolated novel hYVH1-associating proteins from human U2OS osteosarcoma cells using affinity chromatography coupled to mass spectrometry employing ion mobility separation. Numerous ribosomal proteins were identified, confirming the work done in yeast. Furthermore, proteins known to be present on additional RNP particles were identified, including Y box-binding protein 1 (YB-1) and fragile X mental retardation protein, proteins that function in translational repression and stress granule regulation. Follow-up studies demonstrated that hYVH1 co-localizes with YB-1 and fragile X mental retardation protein on stress granules in response to arsenic treatment. Interestingly, hYVH1-positive stress granules were significantly smaller, whereas knocking down hYVH1 expression attenuated stress granule breakdown during recovery from arsenite stress, indicating a possible role for hYVH1 in stress granule disassembly. These results propagate a role for dual specificity phosphatases at RNP particles and suggest that hYVH1 may affect a variety of fundamental cellular processes by regulating messenger ribonucleoprotein (mRNP) dynamics.